Rationale and design of the initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study

Mihai Gheorghiade, Wendy A. Gattis*, Mary Ann Lukas, Christopher M. O'Connor

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

The IMPACT-HF trial is testing a treatment strategy focused on improving the use of β-blockers in the heart failure population. This trial is expected to yield important information about the safety and tolerability of β-blockers, as well as about titration patterns of dosing and response to therapy in patients admitted with heart failure. The results of the IMPACT-HF trial were presented at a satellite symposium at the 2002 American Heart Association Annual Scientific Session.

Original languageEnglish (US)
JournalAmerican Heart Journal
Volume145
Issue number2 SUPPL.
DOIs
StatePublished - Feb 1 2003

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Rationale and design of the initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study'. Together they form a unique fingerprint.

Cite this